J+D release FC365 Lite

This variant of the industry’s most innovative cloud-based forecasting app, FC365, will deliver enhanced forecast model creation with powerful visualisation and detailed reports. With FC365 Lite, clients will benefit from flexible model options and file storage and management within a single, shared environment. Suitable for organisations looking a more manageable segway into a full SaaS system.

Image Credit: J+D Forecasting

J+D have developed FC365 Lite as an alternative to its industry leading FC365 platform application. This offering will support small and mid-size biotech and pharma companies with more targeted product portfolios that might not require all the advanced features and functionality of a full enterprise-wide forecasting solution, but still want to transition to a more robust forecasting NPP or In-line strategic process. FC365 Lite will futureproof forecasting for these clients.

FC365 Lite addresses the most challenging forecasting pain points, resulting in more streamlined processes.

FC365 LITE

Some of the key benefits

  • One stop Teams forecasting app
  • Automated real-time visualisation of forecast outputs
  • Excel forecasting models that drive best practice
  • Explore unlimited scenarios
  • Easy collaboration across teams/business

J+D Forecasting is also recommending FC365 Lite to its existing FC+ software users. With its modular design, existing models can be incorporated into the platform, meaning forecasting teams benefit from automated model management functionality, and experience real-time analysis and reporting.

The FC365 platform has revolutionised our forecasting. Models are easy to find and manage, while the analytic reports give great insights.”

Global Forecasting Manager

Simple IT installation and integration makes FC365 Lite the perfect option, giving forecasting teams the ability to build best practice models, stay in control of the forecast and create insightful reports, all within a single, collaborative environment.

CEO, J+D Forecasting
“J+D are the only specialist pharma forecasting organization delivering expert-driven innovation. FC365 Lite bridges the gap between forecast models and visualisation, with easy transition to a full process management platform, supporting the digital transformation happening within pharmaceutical forecasting right now.”

David James

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    J+D Forecasting. (2023, April 13). J+D release FC365 Lite. News-Medical. Retrieved on July 21, 2024 from https://www.news-medical.net/news/20230324/J2bD-release-FC365-Lite.aspx.

  • MLA

    J+D Forecasting. "J+D release FC365 Lite". News-Medical. 21 July 2024. <https://www.news-medical.net/news/20230324/J2bD-release-FC365-Lite.aspx>.

  • Chicago

    J+D Forecasting. "J+D release FC365 Lite". News-Medical. https://www.news-medical.net/news/20230324/J2bD-release-FC365-Lite.aspx. (accessed July 21, 2024).

  • Harvard

    J+D Forecasting. 2023. J+D release FC365 Lite. News-Medical, viewed 21 July 2024, https://www.news-medical.net/news/20230324/J2bD-release-FC365-Lite.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.